Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.
Wataya-Kaneda M, Nagai H, Ohno Y, Yokozeki H, Fujita Y, Niizeki H, Yoshida K, Ogai M, Yoshida Y, Asahina A, Fukai K, Tateishi C, Hamada I, Takahata T, Shimizu K, Shimasaki S, Murota H. Wataya-Kaneda M, et al. Among authors: fukai k. Dermatol Ther (Heidelb). 2020 Aug;10(4):635-650. doi: 10.1007/s13555-020-00387-7. Epub 2020 May 8. Dermatol Ther (Heidelb). 2020. PMID: 32385845 Free PMC article.
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Wataya-Kaneda M, Ohno Y, Fujita Y, Yokozeki H, Niizeki H, Ogai M, Fukai K, Nagai H, Yoshida Y, Hamada I, Hio T, Shimizu K, Murota H. Wataya-Kaneda M, et al. Among authors: fukai k. JAMA Dermatol. 2018 Jul 1;154(7):781-788. doi: 10.1001/jamadermatol.2018.1408. JAMA Dermatol. 2018. PMID: 29800026 Free PMC article. Clinical Trial.
Guidelines for the diagnosis and treatment of vitiligo in Japan.
Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, Fukai K, Kawakami T, Tsukamoto K, Yamaguchi Y, Sano S, Mitsuhashi Y, Nishigori C, Morita A, Nakagawa H, Mizoguchi M, Katayama I. Oiso N, et al. Among authors: fukai k. J Dermatol. 2013 May;40(5):344-54. doi: 10.1111/1346-8138.12099. Epub 2013 Feb 27. J Dermatol. 2013. PMID: 23441960
Novel ATP2A2 nonsense mutation in a Japanese case with Darier's disease.
Yonezawa E, Tateishi C, Hanabusa M, Fukai K, Nakano H, Sawamura D, Tsuruta D. Yonezawa E, et al. Among authors: fukai k. J Dermatol. 2021 Mar;48(3):e149-e150. doi: 10.1111/1346-8138.15760. Epub 2021 Jan 21. J Dermatol. 2021. PMID: 33476069 No abstract available.
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with advanced stage of cutaneous squamous cell carcinoma.
Kusutani N, Yamanaka-Takaichi M, Yanagishita-Nakatsuji S, Kadoya M, Hasegawa I, Tsutada T, Shimizu J, Ohe S, Isei T, Itoh Y, Fukai K, Tateishi C, Tsuruta D. Kusutani N, et al. Among authors: fukai k. Australas J Dermatol. 2021 Aug;62(3):e460-e462. doi: 10.1111/ajd.13619. Epub 2021 May 24. Australas J Dermatol. 2021. PMID: 34028804 No abstract available.
Mutation analyses of patients with dyschromatosis symmetrica hereditaria: Ten novel mutations of the ADAR1 gene.
Okamura K, Abe Y, Fukai K, Tsuruta D, Suga Y, Nakamura M, Funasaka Y, Oka M, Suzuki N, Wataya-Kaneda M, Seishima M, Hozumi Y, Kawaguchi M, Suzuki T. Okamura K, et al. Among authors: fukai k. J Dermatol Sci. 2015 Jul;79(1):88-90. doi: 10.1016/j.jdermsci.2015.04.004. Epub 2015 Apr 28. J Dermatol Sci. 2015. PMID: 25982145 No abstract available.
491 results